home / stock / clov / clov news


CLOV News and Press, Clover Health Investments Corp. From 10/22/25

Stock Information

Company Name: Clover Health Investments Corp.
Stock Symbol: CLOV
Market: NASDAQ
Website: cloverhealth.com

Menu

CLOV CLOV Quote CLOV Short CLOV News CLOV Articles CLOV Message Board
Get CLOV Alerts

News, Short Squeeze, Breakout and More Instantly...

CLOV - Clover Health to Participate in Upcoming 2025 UBS Global Healthcare Conference

WILMINGTON, Del., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the 2025 UBS Global Healthca...

CLOV - Health insurance premiums rise 6% for U.S. workers in 2025 as GLP-1 coverage widens

2025-10-22 12:20:06 ET More on UnitedHealth, Cigna, etc. Centene: Like ELV, Use The Panic To Buy And Forget Centene: High-Risk Buy With Huge Potential Centene: Strong Buy, For All The Wrong Reasons UnitedHealth tests AI system to streamline medical claims ...

CLOV - Clover Health's Gamble On Technology Worth The Wait

2025-10-22 03:06:29 ET When I last checked in on Clover Health (CLOV), my view was to sit tight and not make any big moves. Back then, it looked like the company was turning a corner, but it still had a lot to prove, especially in making money the old-fashioned way. Fast forward to ...

CLOV - Elevance Health leads managed care gainers after Q3 beat

2025-10-21 07:02:17 ET More on Elevance Health Elevance Health: Undervalued Defensive Giant With Long-Term Upside Elevance Health: Keep It Simple And Buy This Great Business At A Low Valuation Elevance Health: Piggy Bank Or Headache? Elevance Health Non-GAAP ...

CLOV - CLOV Price Target Alert: $3.00. Issued by Leerink Partners

2025-10-21 05:52:59 ET Whit Mayo from Leerink Partners issued a price target of $3.00 for CLOV on 2025-10-21 08:11:00. The adjusted price target was set to $3.00. At the time of the announcement, CLOV was trading at $2.92. The overall price target consensus is at $3.43 w...

CLOV - Market Perform Recommendation Issued On CLOV By Leerink Partners

2025-10-21 05:45:01 ET Leerink Partners analyst issues MARKET PERFORM recommendation for CLOV on October 21, 2025 08:11AM ET. The previous analyst recommendation was Market Perform. CLOV was trading at $2.92 at issue of the analyst recommendation. The overall analyst con...

CLOV - Clover Health's 2026 Medicare Advantage Plans Champion Affordability and Choice

JERSEY CITY, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company dedicated to bringing access to great healthcare to everyone on Medicare, tod...

CLOV - Counterpart Health Expands Proven Flywheel for HEDIS Excellence to Third-Party Partners

SAN FRANCISCO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a l...

CLOV - CVS Health, Clover update on Medicare Star Ratings for 2026

2025-10-10 07:53:24 ET More on Clover Health, CVS CVS Health: A Deeply Undervalued Giant Investors Keep Ignoring CVS Health Vs. UnitedHealth: Companies In Crises - Back United's Recovery CVS Health: Outlier In Healthcare Implosion - Further Margin Recovery Ahead ...

CLOV - Clover Health Comments on 2026 Medicare Advantage Star Ratings and Trajectory for Increasing Profitability into 2027

Company underscores differentiated business model; reiterates confidence in its ability to drive above-market membership growth and increasing Adjusted EBITDA profitability 1 through 2027, independent of Star ratings WILMINGTON, Del., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Clover Health In...

Previous 10 Next 10